Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
- 11 décembre 2024 - 1 mn de lecture
To evaluate, in patients with progressive neuroendocrine tumours who are not eligible to be treated with either surgery or chemotherapy at the moment of study inclusion, the efficacy of lanreotide Autogel in tumour growth stabilization.
11 décembre 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
11 décembre 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
11 décembre 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
11 décembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
11 décembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
11 décembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
11 décembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
11 décembre 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
11 décembre 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
11 décembre 2024
1 mn de lecture